BCM
ANAB icon

Boxer Capital Management’s AnaptysBio ANAB Stock Holding History

Boxer Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,300,000
Closed -$24.2M – 21
2025
Q1 		$24.2M Hold
1,300,000
– – 7.27% 5
2024
Q4 		$17.2M Buy
+1,300,000
New +$31.5M 1.47% 21

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Boxer Capital Management's ANAB Position: Q2 2025 in Review

Boxer Capital Management sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 1,300,000 shares — an estimated $24.2M sold.

Boxer Capital Management first reported a position in ANAB in Q4 2024 and held it in 2 quarters. The position peaked at $24.2M in Q1 2025. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

  • Boxer Capital Management reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
  • Boxer Capital Management sold 1,300,000 AnaptysBio shares in Q2 2025, an estimated $24.2M.
  • Boxer Capital Management first reported a position in AnaptysBio in Q4 2024 and held it in 2 quarters.
  • Boxer Capital Management's AnaptysBio position peaked at $24.2M in Q1 2025.
  • 147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Boxer Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.